Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Egalet Corp (NASDAQ:EGLT)

2.23
Delayed Data
As of Jun 23
 -0.03 / -1.33%
Today’s Change
2.03
Today|||52-Week Range
10.00
-70.85%
Year-to-Date
No recent news for Egalet Corp.

Today’s Trading

Previous close2.26
Today’s open2.26
Day’s range2.21 - 2.39
Volume2,607,756
Average volume (3 months)474,350
Market cap$57.1M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-25.85%
Earnings growth (this year)+12.50%
Earnings growth (next 5 years)--
Revenue growth (last year)-25.69%
P/E ratioNM
Price/Sales11.06
Price/Book10.55

Competitors

 Today’s
change
Today’s
% change
ZSANZosano Pharma Corp+0.05+3.57%
JNPJuniper Pharmaceutic...-0.35-6.31%
EIGREiger BioPharmaceuti...-0.15-2.11%
AGLEAeglea Bio Therapeut...-0.37-9.37%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$17.0M
Annual profit (last year)-$90.6M
Net profit margin-534.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Robert Samuel Radie
Chief Operating Officer &
Executive Vice President
Mark Strobeck
Corporate headquarters
Wayne, Pennsylvania

Forecasts